Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALKS revenue for 2026-06-30 was $888.9M. Net income was -$66.0M. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Use this ALKS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ALKS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ALKS SEC filings page. Lician reads the product cache first so this HTML stays unique to Alkermes Plc even when a live quote feed is slow.
Latest cached year on this hub. Full ALKS income, balance, and cash tables.